EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 234 filers reported holding EXELIXIS INC in Q4 2016. The put-call ratio across all filers is 0.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,681,477 | +215.1% | 351,555 | +175.6% | 0.00% | +300.0% |
| Q2 2023 | $2,437,481 | +31.3% | 127,550 | +33.3% | 0.00% | 0.0% |
| Q1 2023 | $1,856,740 | +12.3% | 95,659 | -7.2% | 0.00% | 0.0% |
| Q4 2022 | $1,653,852 | -57.9% | 103,108 | -58.9% | 0.00% | -50.0% |
| Q3 2022 | $3,931,000 | +1087.6% | 250,601 | +1471.3% | 0.00% | – |
| Q2 2022 | $331,000 | -43.8% | 15,949 | -38.5% | 0.00% | – |
| Q1 2022 | $589,000 | +5.6% | 25,922 | -15.1% | 0.00% | – |
| Q4 2021 | $558,000 | -12.0% | 30,538 | +1.9% | 0.00% | – |
| Q3 2021 | $634,000 | -9.4% | 29,956 | -22.1% | 0.00% | – |
| Q2 2021 | $700,000 | -71.1% | 38,453 | -64.1% | 0.00% | -100.0% |
| Q1 2021 | $2,420,000 | +4.4% | 107,174 | -7.2% | 0.00% | 0.0% |
| Q4 2020 | $2,318,000 | -43.3% | 115,498 | -31.0% | 0.00% | -50.0% |
| Q3 2020 | $4,091,000 | -7.8% | 167,325 | -6.3% | 0.00% | 0.0% |
| Q2 2020 | $4,438,000 | +40.6% | 178,542 | -2.6% | 0.00% | 0.0% |
| Q1 2020 | $3,157,000 | +9.5% | 183,307 | +12.0% | 0.00% | 0.0% |
| Q4 2019 | $2,884,000 | +28.3% | 163,661 | +28.8% | 0.00% | +100.0% |
| Q3 2019 | $2,248,000 | +20.7% | 127,090 | +45.8% | 0.00% | 0.0% |
| Q2 2019 | $1,862,000 | +37.5% | 87,172 | +53.1% | 0.00% | 0.0% |
| Q1 2019 | $1,354,000 | -90.9% | 56,923 | -92.5% | 0.00% | -88.9% |
| Q4 2018 | $14,920,000 | -58.3% | 758,506 | -62.4% | 0.01% | -50.0% |
| Q3 2018 | $35,788,000 | -24.8% | 2,019,640 | -8.6% | 0.02% | -25.0% |
| Q2 2018 | $47,562,000 | +0.6% | 2,210,150 | +3.5% | 0.02% | 0.0% |
| Q1 2018 | $47,289,000 | -34.2% | 2,134,941 | -9.7% | 0.02% | -31.4% |
| Q4 2017 | $71,904,000 | +18.1% | 2,365,271 | -5.8% | 0.04% | +16.7% |
| Q3 2017 | $60,861,000 | +17.7% | 2,511,800 | +19.6% | 0.03% | +15.4% |
| Q2 2017 | $51,713,000 | +13.7% | 2,099,600 | 0.0% | 0.03% | +13.0% |
| Q1 2017 | $45,498,000 | +183.4% | 2,099,600 | +95.0% | 0.02% | +187.5% |
| Q4 2016 | $16,057,000 | – | 1,076,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |